Body-weight maintenance and body composition
A body and individual technology, applied in the direction of organic active ingredients, drug combinations, food ingredients, etc., can solve problems such as weight gain
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0104] Fabuless TM lotion
[0105] A 40 wt% emulsion was prepared with rectified palm oil (batch size 300 g).
[0106]
[0107] Palm oil was melted at 50°C and mixed with rectified oat oil. The oil phase and water were preheated to 65-70°C, then the oil phase was added to the water with high shear mixing at 15,000 rpm over a period of 4 minutes. The pre-emulsion was then divided into two parts; one was homogenized at 400 bar and the other at 800 bar, both at 60°C for 6 cycles (Rannie Homogenizer, Model Mini-Lab 8.30H, APV Rannie ,Denmark).
[0108] Both parts prepared yielded emulsions of similar creamy consistency. The average particle size (Z-mean) in both cases was around 480 nm (Zetasizer 4, Malvern Instruments, UK).
[0109] The emulsion prepared as above (hereinafter referred to as Fabuless TM and marketed by DSM Food Specialties, Delft, The Netherlands) can be stored at 2-8°C until used as an ingredient in the manufacture of the product.
Embodiment 2
[0111] A study of weight maintenance after a period of weight loss
[0112] introduction
[0113] Conduct studies to investigate consumption with or without Fabuless TM Effects of dietary replacement products on weight maintenance and body composition.
[0114] The main purpose is to determine the content of Fabuless TM The effect of a meal replacement product on weight maintenance, which was determined at the time of consumption without Fabuless TM But a meal replacement product with the same fat content was carried out after 12 weeks.
[0115] The secondary objective is to determine the presence or absence of Fabuless TM Meal replacement effects on:
[0116] - fat mass, fat-free mass and bone mass;
[0117] - waist and hip circumference;
[0118] - Body temperature and sagittal measurement;
[0119] - blood pressure and pulse rate; and
[0120] -safety.
[0121] Research design
[0122] The study was a randomized, double-blind, placebo-controlled parallel de...
Embodiment 3
[0191] Additional Statistical Analysis of Caliper Measurements
[0192] Further statistical analysis was performed on skinfold thickness data measured by calipers, a previously established method for calculating body composition. This evaluation was performed at baseline and after 4, 8 and 12 weeks of treatment, and according to Durnin and Wormersly (Brit J. Nutr. (1974) 32 , 77) to calculate body fat mass.
[0193] Statistical evaluations were performed using analysis of variance (ANOVA). The reduction in body fat mass was significantly greater in the active group than in the placebo group, p=0.0108 (see Table 13).
[0194] sheet
[0195] Table 1. Timeline of events
[0196]
[0197] 1 The research nurse will ask the subject if he / she knows this information.
[0198] 2 Co-administration will be known in Observation 1.
[0199] Table 2. Summary results of anterior-posterior measurements and body weight for each treatment. Subjects 1006 and 1036 were excluded. ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More